Feb 14 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.26 7.07 7.40 3.75
(+2.7 pct) (-4.8 pct) (+1.9 pct) (-1.3 pct)
Operating 328 mln 193 mln 200 mln 90 mln
(+70.1 pct) (-62.5 pct) (-39.1 pct) (-61.4 pct)
Recurring 403 mln 397 mln 250 mln 125 mln
(+1.6 pct) (-17.8 pct) (-38.1 pct) (-56.2 pct)
Net
Net 260 mln 237 mln 140 mln 65 mln
(+9.4 pct) (-6.5 pct) (-46.2 pct) (-64.6 pct)
EPS 43.93 yen 40.15 yen 23.62 yen 10.96 yen
Ann Div 14.00 yen 14.00 yen 14.00 yen
-Q2 Div 6.00 yen 6.00 yen 6.00 yen
-Q4 Div 8.00 yen 8.00 yen 8.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T